🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 04335A105
- Market Cap
- Mid Cap · $535 Million
- IPO
- 9/27/2018 · $16.00/share
Business: Arvinas, Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins.
Company Contact
- CEO
- John Houston
- CFO
- Sean Cassidy
- Headquarters
- 5 Science Park, 395 Winchester Ave., New Haven, CT 06511
- Phone
- 203-535-1456
- Investor Relations
- Randy Teel · 203-535-1456 · ir@arvinas.com